Aqua Bio Technology ASA: Share capital increase registered

Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the agreement with the sellers of Jetcarrier AS to convert NOK 50,000,000 of the currently outstanding seller credit into new shares in the Company at the same subscription price as in the private placement that was carried out by the Company 12 February 2026 (the "Conversion"). Reference is further made to the stock exchange announcement by the Company on 13 March 2026 regarding the completion of the extraordinary general meeting in the Company. The general meeting inter alia resolved to increase the Company's share capital by NOK 50,000,000 through the issuance of 10,000,000 new shares in connection with the Conversion, each with a par value of NOK 5.00. The share capital increase pertaining to the Conversion has now been registered with the Norwegian Register of Business Enterprises. The new share capital of ABTEC is NOK 76,139,675 divided by 15,227,935 shares, each with a par value of NOK 5.00.

Contacts Kristian Flaten CEO & CFO Aqua Bio Technology ASA

Phone: +47 9509 2322 Email: kf@aquabiotech.no

About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-23 12:02 CET.